Companies like Eli Lilly and GlaxoSmithKline are investing in automation with the hope of transforming drug discovery from an enterprise where humans do manual experiments to one where robots handle thousands of samples around the clock.
from WSJ.com: US Business https://ift.tt/2kPJ8Ng
via IFTTT
No comments:
Post a Comment